Product image of Atectura Breezhaler (Mometasone Furoate, Indacaterol) supplied by GNH India

Atectura Breezhaler

Active Ingredient:
Mometasone Furoate, Indacaterol
Origin:
EU

Atectura Breezhaler (Mometasone Furoate, Indacaterol)

Atectura Breezhaler is a combination inhaler containing Mometasone Furoate and Indacaterol, designed for inhalation use. It is commonly used for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). This medication helps to reduce inflammation and improve breathing.

Manufacturer / TM Owner

Novartis Europharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Atectura Breezhaler is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). The combination of Mometasone Furoate and Indacaterol works to reduce airway inflammation and relax the muscles around the airways, making it easier to breathe. This inhaler is often prescribed for individuals who require both an inhaled corticosteroid and a long-acting beta-agonist for effective symptom control.

Side Effects

  • Common effects of Atectura Breezhaler may include improved breathing and reduced symptoms of asthma or COPD. Some users may experience mild side effects such as throat irritation, hoarseness, or a dry mouth. These effects are generally temporary and should subside as the body adjusts to the medication.

Precautions & Warnings

  • Atectura Breezhaler should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions to ensure optimal effectiveness and safety. Patients should be aware of potential side effects and consult their healthcare provider if they experience any unusual symptoms.

Avoid Interactions

  • Atectura Breezhaler may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, patients should be cautious when using this inhaler with other respiratory medications.

Frequently Asked Questions

Atectura Breezhaler is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It helps to reduce inflammation and improve breathing.

Atectura Breezhaler combines Mometasone Furoate, which reduces inflammation, and Indacaterol, which relaxes airway muscles, making it easier to breathe.

Common side effects may include throat irritation, hoarseness, and a dry mouth. These effects are usually mild and temporary.

Atectura Breezhaler may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Atectura Breezhaler should be stored at room temperature, away from moisture and heat. Always keep it out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate, Indacaterol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT